Looking for a stock that might be in a good position to beat
earnings at its next report? Consider
), a firm in the Pharmacy Services industry, which could be a great
candidate for another beat.
This company has seen a nice streak of beating earnings estimates,
especially when looking at the previous two reports. In fact, in
these reports, PMC has beaten estimates by at least 30% in both
cases, suggesting it has a nice short-term history of crushing
Earnings in Focus
Two quarters ago, PMC expected to earn 31 cents per share, while it
actually produced earnings of 41 cents per share, a beat of 32.3%.
Meanwhile, for the most recent quarter, the company looked to
deliver earnings of 29 cents per share, when it actually saw
earnings of 43 cents per share instead, representing a 48.3%
Thanks in part to this history, recent estimates have been moving
higher for PharMerica. In fact, the
for PMC is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate
estimate to the broad consensus, looking to find stocks that have
seen big revisions as of late, suggesting that analysts have
recently become more bullish on the company's earnings prospects.
This is the case for PMC, as the firm currently has a Zacks
Earnings ESP of 9.09%, so another beat could be around the corner.
This is particularly true when you consider that PMC has a great
Zacks Rank #3 (Hold) which can be a harbinger of outperformance and
a signal for a strong earnings profile. And when you add this solid
Zacks Rank to a positive Earnings ESP,
a positive earnings surprise happens nearly 70%
of the time, so it seems pretty likely that PMC could see another
beat at its next report, especially if recent trends are any guide.
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
PHARMERICA CORP (PMC): Free Stock Analysis
To read this article on Zacks.com click here.